ML-Based Multi-Sensor Fall Risk Screening in DMD
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Performance of the Upper Limb, Brooke Scale, grip strength test.
- Who it may be relevant to
- Registry conditions: DMD. Basic parameters: 10 years — 30 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Quantitative Analysis of Upper Extremity Functional Movement of the Upper Extremity in Patients With Duchenne Muscular Dystrophy
Overview
This prospective observational study aims to analyze changes in upper extremity functional movement over time in children with Duchenne Muscular Dystrophy (DMD). Thirty patients will be evaluated at three time points (baseline, 6 months, 12 months) using clinical assessments (PUL 2.0, Brooke Scale, grip strength), computer vision-based video analysis, and machine learning algorithms. The goal is to improve future upper limb evaluation methods for non-ambulatory DMD patients. The study includes safety monitoring and adheres to ethical standards, ensuring patient data confidentiality and providing compensation if adverse effects occur.
Interventions
- Other Performance of the Upper Limb, Brooke Scale, grip strength test
Thirty patients will be evaluated at three time points (baseline, 6 months, 12 months) using clinical assessments (PUL 2.0, Brooke Scale, grip strength), computer vision-based video analysis, and machine learning algorithms.
Primary outcome measures
- Performance of the upper limb module 2.0 [Time frame: baseline - 6 months - 12 months]
Secondary outcome measures (2)
- Brooke score [Time frame: baseline - 6 months - 12 months]
- grip strength [Time frame: baseline - 6 months - 12 months]
Eligibility criteria
Inclusion criteria
- Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy (DMD)
- Age over 10 and under 30 years
- Brooke Scale score between 2 and 5
- Manual muscle test grade below 3 for shoulder abduction muscles
Exclusion criteria
- Individuals who are unable or unwilling to provide informed consent
- Brooke Scale score of 1 or 6
- Individuals with cognitive impairments that significantly limit their ability to participate in assessments
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
South Korea · 1 center
- Seoul National University Hospital — Seoul
Identifiers
NCT: NCT07015632 · 0420232060